Kynurenine pathway of tryptophan metabolism: Regulatory and functional aspects

International Journal of Tryptophan Research

Volumn 10, Issue 1, 2017, Pages

  Badawy, Abdulla A B ^a  

^a CARDIFF METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

Indoleamine 2,3 dioxygenase; Kynureninase; Kynurenine aminotransferase; Nicotinamide; Tryptophan 2,3 dioxygenase; Tryptophan disposition

Indexed keywords

EID: 85020998625     PISSN: None     EISSN: 11786469     Source Type: Journal    
DOI: 10.1177/1178646917691938     Document Type: Review

References (203)

1. Bender DA. Biochemistry of tryptophan in health and disease. Mol Aspects Med. 1983;6:1-97
2. Badawy AA-B. Tryptophan metabolism in alcoholism. Nutr Res Rev. 2002;1:123-152
3. Badawy AA-B. Tryptophan metabolism, disposition and utilization in pregnancy. Biosci Rep. 2015;35:e00261
4. Badawy AA-B. Pellagra and alcoholism: a biochemical perspective. Alcohol Alcohol. 2014;49:238-250
5. Chiarugi A, Carpenedo R, Molina MT, Mattoli L, Pellicciari R, Moroni F. Comparison of the neurochemical and behavioral effects resulting from the inhibition of kynurenine hydroxylase and/or kynureninase. J Neurochem. 1995;65:1176-1183
6. Nishizuka Y, Hayaishi O. Studies on the biosynthesis of nicotinamide adenine nucleotides I. Enzymatic synthesis of niacin ribonucleotides from 3-hydroxyanthranilic acid in mammalian tissue. J Biol Chem. 1963;238:3369-3377
7. Bender DA. Inhibition in vitro of the enzymes of the oxidative pathway of tryptophan metabolism and of nicotinamide nucleotide synthesis by benserazide, carbidopa and isoniazid. Biochem Pharmacol. 1980;29:707-712
8. www.brenda-enzymes.org
9. Werner ER, Werner-Felmayer G. Substrate and cofactor requirements of indoleamine 2,3-dioxygenase in interferon-gamma-treated cells: utilization of oxygen rather than superoxide. Curr Drug Metab. 2007;8:97-101
10. Badawy AA-B. Tryptophan availability for kynurenine pathway metabolism across the life span: control mechanisms and focus on aging, exercise, diet and nutritional supplements. Neuropharmacology. 2015;112:248-263
11. Kanai M, Nakamura T, Funakoshi H. Identification and characterization of novel variants of the tryptophan 2,3-dioxygenase gene: differential regulation in the mouse nervous system during development. Neurosci Res. 2009;64: 111-117
12. Opitz CA, Litzenburger UM, Sahm F, et al. An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature. 2011;478:197-203
13. Ball HJ, Yuasa HJ, Austin CJ, Weiser S, Hunt NH. Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway. Int J Biochem Cell Biol. 2009;41:467-471
14. Fukunaga M, Yamamoto Y, Kawasoe M, et al. Studies on tissue and cellular distribution of indoleamine 2,3-dioxygenase 2: the absence of IDO1 upregulates IDO2 expression in the epididymis. J Histochem Cytochem. 2012;60: 854-860
15. Meininger D, Zalameda L, Liu Y, et al. Purification and kinetic characterization of human indoleamine 2,3-dioxygenase 1 and 2 (IDO1 and IDO2) and discovery of selective IDO1 inhibitors. Biochim Biophys Acta. 2011;1814:1947-1954
16. Pabarcus MK, Casida JE. Cloning, expression, and catalytic triad of recombinant arylformamidase. Protein Expr Purif. 2005;44:39-44
17. Müller F. Flavin-dependent hydroxylases. Biochem Soc Trans. 1985;13:443-447
18. Verjee ZHM. Tryptophan metabolism in baboons: effect of riboflavin and pyridoxine deficiency. Acta Vitaminol Enzymol (Milano). 1975;29:198-201
19. Clayton PT, Bridges NA, Atherton DJ, Milla PJ, Malone M, Bender DA. Pellagra with colitis due to a defect in tryptophan metabolism. Eur J Pediatr. 1991;150:498-502
20. Bender DA. Tryptophan and niacin nutrition-is there a problem? Adv Exp Med Biol. 1996;398:565-567
21. Knox WE. The relation of liver kynureninase to tryptophan metabolism in pyridoxine deficiency. Biochem J. 1953;53:379-385
22. Takeuchi F, Shibata Y. Kynurenine metabolism in vitamin-B-6-deficient rat liver after tryptophan injection. Biochem J. 1984;220:693-699
23. Bender DA, Njagi ENM, Danielian PS. Tryptophan metabolism in vitamin B6-deficient mice. Br J Nutr. 1990;63:27-36
24. Badawy AA-B, Lake SL, Dougherty DM. Mechanisms of the pellagragenic effect of leucine: stimulation of hepatic tryptophan oxidation by administration of branched-chain amino acids to healthy human volunteers and the role of plasma free tryptophan and total kynurenines. Int J Tryptophan Res. 2014;7:23-32
25. Bender DA, Laing AE, Vale JA, Papadaki J, Pugh M. The effects of oestrogen administration on tryptophan metabolism in rats and in menopausal women receiving hormone replacement therapy. Biochem Pharmacol. 1983;32:843-848
26. Bender DA, Totoe L. Inhibition of tryptophan metabolism by oestrogens in the rat: a factor in the aetiology of pellagra. Br J Nutr. 1984;51:219-224
27. Walsh HA, Botting NP. Purification and biochemical characterization of some of the properties of recombinant human kynureninase. Eur J Biochem. 2002;269:2069-2074
28. Inada J, Okuno E, Kimura M, Kido R. Intracellular localization and characterization of 3-hydroxykynureninase in human liver. Int J Biochem. 1984;16:623-628
29. Badawy AA-B, Dougherty DM. Assessment of the human kynurenine pathway: comparisons and clinical implications of ethnic and gender differences in plasma tryptophan, kynurenine metabolites, and enzyme expressions at baseline and after acute tryptophan loading and depletion. Int J Tryptophan Res. 2016;9:31-49
30. Han Q, Cai T, Tagle DA, Li J. Thermal stability, pH dependence and inhibition of four murine kynurenine aminotransferases. BMC Biochem. 2010;11:19
31. Han Q, Robinson H, Cai T, Tagle DA, Li J. Biochemical and structural properties of mouse kynurenine aminotransferase III. Mol Cell Biol. 2009;29:784-793
32. Han Q, Cai T, Tagle DA, Robinson H, Li J. Substrate specificity and structure of human aminoadipate aminotransferase/kynurenine aminotransferase II. Biosci Rep. 2008;28:205-215
33. Stachowski EK, Schwarcz R. Regulation of quinolinic acid neosynthesis in mouse, rat and human brain by iron and iron chelators in vitro. J Neural Transm. 2012;119:123-131
34. Okuno E, Köhler C, Schwarcz R. Rat 3-hydroxyanthranilic acid oxygenase: purification from the liver and immunocytochemical localization in the brain. J Neurochem. 1987;49:771-780
35. Malherbe P, Kohler C, Da Prada M, et al. Molecular cloning and functional expression of human 3-hydroxyanthranilic-acid dioxygenase. J Biol Chem. 1994;269:13792-13797
36. Tanabe A, Egashira Y, Fukuoka S-I, Shibata K, Sanada H. Purification and molecular cloning of rat 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase. Biochem J. 2002;361:567-575
37. Pucci L, Perozzi S, Cimadamore F, Orsomando G, Raffaelli N. Tissue expression and biochemical characterization of human 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase, a key enzyme in tryptophan catabolism. FEBS J. 2007;274:82740
38. Bender DA. Effects of a dietary excess of leucine on the metabolism of tryptophan in the rat: a mechanism for the pellagragenic action of leucine. Br J Nutr. 1983;50:25-32
39. He Z, Davis JK, Spain JC. Purification, characterization, and sequence analysis of 2-aminomuconic 6-semialdehyde dehydrogenase from Pseudomonas pseudoalcaligenes JS45. J Bacteriol. 1998;180:4591-4595
40. Liu H, Woznica K, Catton G, Crawford A, Botting N, Naismith JH. Structural and kinetic characterization of quinolinate phosphoribosyltransferase (hQPRTase) from Homo sapiens. J Mol Biol. 2007;373:755-763
41. Ikeda M, Tsuji H, Nakamura S, Ichiyama A, Nishizuka Y, Hayaishi O. Studies on the biosynthesis of nicotinamide adenine dinucleotide. II. A role of picolinic carboxylase in the biosynthesis of nicotinamide adenine dinucleotide from tryptophan in mammals. J Biol Chem. 1965;240:1395-1401
42. Imsande J, Handler P. Biosynthesis of diphosphopyridine nucleotide III. Nicotinic acid mononucleotide pyrophosphorylase. J Biol Chem. 1961;236:525-530
43. Hara N, Yamada K, Shibata T, Osago H, Hashimoto T, Tsuchiya M. Elevation of cellular NAD levels by nicotinic acid and involvement of nicotinic acid phosphoribosyltransferase in human cells. J Biol Chem. 2007;282:24574-24582
44. Bender DA, Magboul BI, Wynick D. Probable mechanisms of regulation of the utilization of dietary tryptophan, nicotinamide and nicotinic acid as precursors of nicotinamide nucleotides in the rat. Br J Nutr. 1982;48:119-127
45. Burgos ES, Schramm VL. Weak coupling of ATP hydrolysis to the chemical equilibrium of human nicotinamide phosphoribosyltransferase. Biochemistry. 2008;47:11086-11096
46. Wintzerith M, Dierich A, Mandel P. Purification and characterization of a nicotinamide deamidase released into the growth medium of neuroblastoma in vitro. Biochim Biophys Acta. 1980;613:191-202
47. Petrack B, Greengard P, Craston A, Sheppy F. Nicotinamide deamidase from mammalian liver. J Biol Chem. 1965;240:1725-1730
48. Lau C, Niere M, Ziegler M. The NMN/NaMN adenylyltransferase (NMNAT) protein family. Front Biosci. 2009;14:410-431
49. Hara N, Yamada K, Terashima M, Osago H, Shimoyama M, Tsuchiya M. Molecular identification of human glutamine-and ammonia-dependent NAD synthetases. Carbon-nitrogen hydrolase domain confers glutamine dependency. J Biol Chem. 2003;278:10914-10921
50. Shibata K, Hayakawa T, Iwai K. Tissue distribution of the enzymes concerned with the biosynthesis of NAD in rats. Agr Biol Chem. 1986;50:3037-3041
51. Felsted R, Chu AE-Y, Chaykin S. Purification and properties of the aldehyde oxidases from hog and rabbit livers. J Biol Chem. 1973;248:2580-2587
52. Shibata K, Matsuo H. Correlation between niacin equivalent intake and urinary excretion of its metabolites, N'-methylnicotinamide, N'-methyl-2-pyridone-5-carboxamide, and N'-methyl-4-pyridone-3-carboxamide, in humans consuming a self-selected food. Am J Clin Nutr. 1989;50:114-119
53. Badawy AA-B, Evans M. Animal liver tryptophan pyrrolases: absence of hormonal induction mechanism from species sensitive to tryptophan toxicity. Biochem J. 1976;158:79-88
54. De Castro FT, Brown RR, Price JM. The intermediary metabolism of tryptophan by cat and rat tissue preparations. J Biol Chem. 1957;228:777-784
55. Allegri G, Bertazzo A, Biasiolo M, Costa CVL, Ragazzi E. Kynurenine pathway enzymes in different species of animals. Adv Exp Med Biol. 2003;527:455-463
56. Murakami Y, Saito K. Species and cell type difference in tryptophan metabolism. Int J Tryptophan Res. 2013;6:47-54
57. Knox WE, Greengard O. The regulation of some enzymes of nitrogen metabolism-an introduction to enzyme physiology. Adv Enzyme Regul. 1965;3:247-313
58. Feigelson P, Greengard O. Metabolic effects of glucocorticoids as related to enzyme induction. Adv Enzyme Regul. 1965;3:11-27
59. Schimke RT, Sweeney EW, Berlin CM. The role of synthesis and degradation in the control of rat liver tryptophan pyrrolase. J Biol Chem. 1965;240:322-331
60. Hayaishi O. My life with tryptophan-never a dull moment. Protein Sci. 1993;2:472-475
61. Badawy AA-B, Evans M. Regulation of rat liver tryptophan pyrrolase by its cofactor haem: experiments with haematin and 5-aminolaevulinate and comparison with the substrate and hormonal mechanisms. Biochem J. 1975;150:511-520
62. Badawy AAB. Tryptophan: the key to boosting brain serotonin synthesis in depressive illness. J Psychopharmacol. 2013;27:878-893
63. Badawy AA-B, Welch AN, Morgan CJ. Tryptophan pyrrolase in haem regulation. The mechanism of the opposite effects of tryptophan on rat liver 5-aminolaevulinate synthase activity and the haem saturation of tryptophan pyrrolase. Biochem J. 1981;198:309-314
64. Ren S, Correia MA. Heme: a regulator of rat hepatic tryptophan 2,3-dioxygenase? Arch Biochem Biophys. 2000;377:195-203
65. Liao M, Pabarcus MK, Wang YQ, et al. Impaired dexamethasone-mediated induction of tryptophan 2,3-dioxygenase in heme-deficient rat hepatocytes: translational control by a hepatic eIF2alpha kinase, the heme-regulated inhibitor. J Pharmacol Exp Ther. 2007;323:979-989
66. Danesch U, Hashimoto S, Renkawitz R, Schutz G. Transcriptional regulation of the tryptophan oxygenase gene in rat liver by glucocorticoids. J Biol Chem. 1983;258:4750-4753
67. Nakamura T, Niimi S, Nawa K, et al. Multihormonal regulation of transcription of the tryptophan 2,3-dioxygenase gene in primary cultures of adult rat hepatocytes with special reference to the presence of a transcriptional protein mediating the action of glucocorticoids. J Biol Chem. 1987;262:723-732
68. Schmid W, Scherer G, Danesch U, et al. Isolation and characterization of the rat tryptophan oxygenase gene. EMBO J. 1982;1:1287-1293
69. Hirota T, Hirota K, Sanno Y, Tanaka T. Appearance of new hepatic glucocorticoid binding proteins under various stressful conditions: relation to endogenous glucocorticoid secretion. J Biochem (Tokyo). 1985;97:1371-1376
70. Hirota T, Hirota K, Sanno Y, Tanaka T. A new glucocorticoid receptor species: relation to induction of tryptophan dioxygenase by glucocorticoids. Endocrinology. 1985;117:1788-1795
71. Nakamura T, Shinno H, Ichihara A. Insulin and glucagon as a new regulator system for tryptophan oxygenase activity demonstrated in primary cultured rat hepatocytes. J Biol Chem. 1980;255:7533-7535
72. Broqua P, Baudrie V, Laude D, Guezennec Y, Chaouloff F. In vivo evidence that insulin does not inhibit hepatic tryptophan pyrrolase activity in rats. Biochem Pharmacol. 1990;40:759-763
73. Labrie F, Korner A. Effect of glucagon, insulin, and thyroxine on tyrosine transaminase and tryptophan pyrrolase of rat liver. Arch Biochem Biophys. 1969;129:75-78
74. Yamamoto M, Hayashi N, Kikuchi G. Increase in liver heme concentration after the administration of insulin, glucagon and dibutyryl cyclic AMP to rats and its relevance to regulation of d-aminolevulinate synthase. Biochem Int. 1982;5:747-754
75. Hagen JH. Effect of glucagon on the metabolism of adipose tissue. J Biol Chem. 1961;236:1023-1027
76. Carlson MG, Snead WL, Campbell PJ. Regulation of free fatty acid metabolism by glucagon. J Clin Endocrinol Metab. 1993;77:11-15
77. Granick S, Sinclair P, Sassa S, Grieninger G. Effects by heme, insulin, and serum albumin on heme and protein synthesis in chick embryo liver cells cultured in a chemically defined medium, and a spectrofluorometric assay for porphyrin composition. J Biol Chem. 1975;250:9215-9225
78. Badawy AA-B, Evans M. Effects of streptozotocin on the concentrations of rat liver nicotinamide-adenine dinucleotides (phosphates) and the activity of tryptophan pyrrolase. Biochem Soc Trans. 1977;5:1314-1316
79. Bitar M, Weiner M. Diabetes-induced metabolic alterations in heme synthesis and degradation and various heme-containing enzymes in female rats. Diabetes. 1984;33:37-44
80. Salter M, Pogson CI. The role of tryptophan 2,3-dioxygenase in the hormonal control of tryptophan metabolism in isolated rat liver cells. Effects of glucocorticoids and experimental diabetes. Biochem J. 1985;229:499-504
81. Chiancone FM. Enzyme activities in the tryptophan nicotinic acid path in physiopathology. Ital J Biochem. 1964;13:1-30
82. Badawy AA-B, Evans M. The role of free serum tryptophan in the biphasic effect of acute ethanol administration on the concentrations of rat brain tryptophan, 5-hydroxytryptamine and 5-hydroxyindol-3-ylacetic acid. Biochem J. 1976;160:315-324
83. Ku Y, Rogers QR, Harper AE. Effects of thyroxine and cortisol on liver threonine dehydratase and tryptophan pyrrolase in rats fed a high protein diet. Proc Soc Exp Biol Med. 1969;130:556-563
84. Wagner C. Regulation of the tryptophan-nicotinic acid-DPN pathway in the rat. Biochem Bioph Res Co. 1964;17:668-673
85. Cho-Chung YS, Pitot HC. Feedback control of rat liver tryptophan pyrrolase. J Biol Chem. 1967;242:1192-1198
86. Badawy AA-B, Evans M. The regulation of rat liver tryptophan pyrrolase activity by reduced nicotinamide-adenine dinucleotide (phosphate). Experiments with glucose and nicotinamide. Biochem J. 1976;156:381-390
87. Badawy AA-B, Bano S. Tryptophan metabolism in rat liver after administration of tryptophan, kynurenine metabolites, and kynureninase inhibitors. Int J Tryptophan Res. 2016;9:51-65
88. Yoshida R, Nukiwa T, Watanabe Y, Fujiwara M, Hirata F, Hayaishi O. Regulation of indoleamine 2,3-dioxygenase activity in the small intestine and the epididymis of mice. Arch Biochem Biophys. 1980;203:343-351
89. Cook JS, Pogson CI, Smith SA. Indoleamine 2,3-dioxygenase. A new, rapid, sensitive radiometric assay and its application to the study of the enzyme in rat tissues. Biochem J. 1980;189:461-466
90. Badawy AA-B. Possible involvement of the enhanced tryptophan pyrrolase activity in the corticosterone-and starvation-induced increases in concentrations of nicotinamide-adenine dinucleotides (phosphates) in rat liver. Biochem J. 1981;196:217-224
91. Ozaki Y, Reinhard JF Jr, Nichol CA. Cofactor activity of dihydroflavin mononucleotide and tetrahydrobiopterin for murine epididymal indoleamine 2,3-dioxygenase. Biochem Biophys Res Commun. 1986;137:1106-1111
92. Efimov I, Basran J, Sun X, et al. The mechanism of substrate inhibition in human indoleamine 2,3-dioxygenase. J Am Chem Soc. 2012;134:3034-3041
93. Pfefferkorn ER, Rebhun S, Eckel M. Characterization of an indoleamine 2,3-dioxygenase induced by gamma-interferon in cultured human fibroblasts. J Interferon Res. 1986;6:267-279
94. Ozaki Y, Edelstein MP, Duch DS. The actions of interferon and antiinflammatory agents on induction of indoleamine 2,3-dioxygenase in human peripheral blood monocytes. Biochem Biophys Res Commun. 1987;144:1147-1153
95. Hucke C, MacKenzie CR, Adjogble KD, Takikawa O, Daubener W. Nitric oxide-mediated regulation of gamma interferon-induced bacteriostasis: inhibition and degradation of human indoleamine 2,3-dioxygenase. Infect Immun. 2004;72:2723-2730
96. Thomas SR, Terentis AC, Cai H, et al. Post-translational regulation of human indoleamine 2,3-dioxygenase activity by nitric oxide. J Biol Chem. 2007;282:23778-23787
97. Badawy AA-B. Plasma free tryptophan revisited: what you need to know and do before measuring it. J Psychopharmacol. 2010;24:809-815
98. Badawy AA-B, Namboodiri AM, Moffett JR. The end of the road for the tryptophan depletion concept in pregnancy and infection. Clin Sci. 2016;130:1327-1333
99. Smith SA, Pogson CI. The metabolism of L-tryptophan by isolated rat liver cells. Effect of albumin binding and amino acid competition on oxidation of tryptophan by tryptophan 2,3-dioxygenase. Biochem J. 1980;186:977-986
100. Smith SA, Carr FPA, Podson CI. The metabolism of L-tryptophan by isolated rat liver cells. Quantification of the relative importance of, and the effect of nutritional status on, the individual pathways of tryptophan metabolism. Biochem J. 1980;192:673-686
101. Smith SA, Pogson CI. The metabolism of L-tryptophan by liver cells prepared from adrenalectomized and streptozotocin-diabetic rats. Biochem J. 1981;200:605-609
102. Salter M, Stanley JC, Fisher MJ, Pogson CI. The influence of starvation and tryptophan administration on the metabolism of phenylalanine, tyrosine and tryptophan in isolated rat liver cells. Biochem J. 1984;221:431-438
103. Knox WE. The regulation of tryptophan pyrrolase activity by tryptophan. Adv Enzyme Regul. 1966;4:287-297
104. Horita A, Carino MA. Nodifiction of the toxic actions of L=tryptophan by pargyline and p-chlorophenylalanine. Biochem Pharmacol. 1970;19:1521-1524
105. Badawy AA-B. Tryptophan and inhibitors of tryptophan 2,3-dioxygenase as antidepressants: reply. J Psychopharmacol. 2014;28:169-172
106. Muñoz-Clares RA, Lloyd P, Lomax MA, Smith SA, Pogson CI. Tryptophan metabolism and its interaction with gluconeogenesis in mammals: studies with the guinea pig, Mongolian gerbil, and sheep. Arch Biochem Biophys. 1981;209:713-717
107. Kanai M, Funakoshi H, Takahashi H, et al. Tryptophan 2,3-dioxygenase is a key modulator of physiological neurogenesis and anxiety-related behaviour in mice. Mol Brain. 2009;2:8
108. Terakata M, Fukuwatari T, Kadota E, et al. The niacin required for optimum growth can be synthesized from L-tryptophan in growing mice lacking tryptophan-2,3-dioxygenase. J Nutr. 2013;143:1046-1051
109. Santillan MK, Pelham CJ, Gibson-Corley KN, Scroggins SM. Pregnant mice lacking indoleamine 2,3-dioxygenase exhibit preeclampsia phenotypes. Physiol Rep. 2015;3:e12257
110. Too LK, Li KM, Suarna C, et al. Deletion of TDO2, IDO-1 and IDO-2 differentially affects mouse behavior and cognitive function. Behav Brain Res. 2016;312:102-117
111. Badawy AA-B, Evans M. Opposite effects of chronic administration and subsequent withdrawal of drugs of dependence on the metabolism sand disposition of endogenous and exogenous tryptophan in the rat. Alcohol Alcohol. 1983;18:369-382
112. Politi V, D'Alessioi S, Stazio G, De Luca G. Antioxidant properties of indole-3-pyruvic acid. Adv Exp Med Biol. 1996;398:291-298
113. Werner ER, Fuchs D, Hausen A, et al. Tryptophan degradation in patients infected by human immunodeficiency virus. Biol Chem Hoppe Seyler. 1988;369:337-340
114. Fuchs D, Forsman A, Hagberg L, et al. Immune activation and decreased tryptophan in patients with HIV-1 infection. J Interferon Res. 1990;10:599-603
115. Stone TW. Neuropharmacology of quinolinic and kynurenic acids. Pharmacol Rev. 1993;45:309-385
116. Wu H-Q, Okuyama M, Kajii Y, Pocivavsek A, Bruno JP, Schwarcz R. Targeting kynurenine aminotransferase II in psychiatric diseases: promising effects of an orally active enzyme inhibitor. Schizophr Bull. 2014;40:S152-S158
117. Cherian AK, Gritton H, Johnson De, Young D, Koza R, Sarter M. A systemically-available kynurenine aminotransferase II (KAT II) inhibitor restores nicotine-evoked glutamatergic activity in the cortex of rats. Neuropharmacology. 2014;82:41-48
118. Jayawickrama GS, Sadig RR, Sun G, et al. Kynurenine aminotransferases and the prospects of inhibitors for the treatment of schizophrenia. Curr Med Chem. 2015;22:29202-29218
119. Linderholm KR, Skogh E, Olsson SK, et al. Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia. Schizophr Bull. 2012;3:426-432
120. Beck K, Javitt DC, Howes OD. Targeting glutamate to treat schizophrenia: lessons from recent clinical studies. Psychopharmacol. 2016;233:2425-2428
121. Chouinard G, Annable L, Serrano M, Charette R. A controlled study of a dopa decarboxylase inhibitor (benserazide) in the treatment of schizophrenic patients. Int Pharmacopsychiatry. 1977;12:1-8
122. Chouinard G, Annable L, Young SN, Sourkes TL. A controlled study of tryptophan-benserazide in schizophrenia. Commun Psychopharmacol. 1978;2:21-31
123. Malaczewska J, Siwicki AK, Wójcik RM, Turski WA, Kaczorek E. The effect of kynurenic acid on the synthesis of selected cytokines by murine splenocytes-in vitro and ex vivo studies. Cent Eur J Immunol. 2016;41:39-46
124. Moroni F, Cozzi A, Sili M, Mannaioni G. Kynurenic acid: a metabolite with multiple actions and multiple targets in brain and periphery. J Neural Transm. 2012;119:133-139
125. Darlington LG, Forrest CM, Mackay GM, Smith RA, Smith AJ, Stone TW. On the biological importance of the 3-hydroxyanthranilic acid: anthranilic acid ratio. Int J Tryptophan Res. 2010;3:51-59
126. Darlington LG, Mackay GM, Forrest CM, Stoy N, George C, Stone TW. Altered kynurenine metabolism correlates with infarct volume in stroke. Eur J Neurosci. 2007;26:2211-2221
127. Oxenkrug G, van der Hart M, Roeser J, Summergrad P. Anthranilic acid: a potential biomarker and treatment target for schizophrenia. Ann Psychiatry Ment Health. 2016;4:1059
128. Murray HW, Szuro-Sudol A, Wellner D, et al. Role of tryptophan degradation in respiratory burst-independent antimicrobial activity of gamma interferonstimulated human macrophages. Infect Immun. 1989;57:845-849
129. Pfefferkorn ER, Eckel M, Rebhun S. Interferon-gamma suppresses the growth of Toxoplasma gondii in human fibroblasts through starvation for tryptophan. Mol Biochem Parasitol. 1986;20:215-224
130. Taylor MW, Feng GS. Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J. 1991;5:2516-2522
131. Munn DH, Zhou M, Attwood JT, et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science. 1998;281:1191-1193
132. Moffett JR, Namboodiri MA. Tryptophan and the immune response. Immunol Cell Biol. 2003;81:247-265
133. Badawy AA-B. The tryptophan utilization concept in pregnancy. Obstet Gynecol Sci. 2014;5:249-259
134. Chen Y, Guillemin GL. Kynurenine pathway metabolites in humans: disease and healthy states. Int J Tryptophan Res. 2009;2:1-19
135. Schwarcz R, Tamminga CA, Kurlan R, Shoulson I. Cerebrospinal fluid levels of quinolinic acid in Huntington's disease and schizophrenia. Ann Neurol. 1988;24:580-582
136. Goda K, Hamane Y, Kishimoto R, Ogishi Y. Radical scavenging properties of tryptophan metabolites. Adv Exp Med Biol. 1999;467:397-402
137. Krause D, Suh H-S, Tarassishin L, et al. The tryptophan metabolite 3-hydroxyanthranilic acid plays anti-inflammatory and neuroprotective roles during inflammation: role of hemeoxygenase-1. Am J Pathol. 2011;179:1360-1372
138. Smith SA, Pogson CI. Tryptophan and the control of plasma tryptophan concentration in the rat. Biochem J. 1977;168:495-506
139. Reginaldo C, Jacques P, Scott T, Oxenkrug G, Selhub J, Paul L. Xanthurenic acid is associated with higher insulin resistance and higher odds of diabetes. FASEB J. 2015;29:20
140. Ikeda S, Kotake Y. Urinary excretion of xanthurenic acid and zinc in diabetes: (3). Occurrence of xanthurenic acid-Zn2+ complex in urine of diabetic patients and of experimentally-diabetic rats. Ital J Biochem. 1986;35:232-241
141. Oxenkrug GF. Increased plasma levels of xanthurenic and kynurenic acids in type 2 diabetes. Mol Neurobiol. 2015;52:805-810
142. Chausmer AB. Zinc, insulin and diabetes. J Am Coll Nutr. 1998;17:109-115
143. Mehler AH, McDaniel EG, Hundley JM. Changes in the enzymatic composition of liver. I. Increase of picolinic carboxylase in diabetes. J Biol Chem. 1958;232:323-330
144. Tanabe A, Egashira Y, Fukuoka S-I, Shibata K, Sanada H. Expression of rat hepatic 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase is affected by a high protein diet and by streptozotocin-induced diabetes. J Nutr. 2002;132:1153-1159
145. Sasaki N, Egashira Y, Sanada H. Production of L-tryptophan-derived catabolites in hepatocytes from streptozotocin-induced diabetic rats. Eur J Nutr. 2009;48:145-153
146. Zuwala-Jagiello J, Pazgan-Simon M, Simon K, Warwas M. Picolinic acid in patients with chronic hepatitis C infection: a preliminary report. Mediat Inflamm. 2012;2012:762863
147. Medana IM, Day NPJ, Salahifar-Sabet H, et al. Metabolites of the kynurenine pathway of tryptophan metabolism in the cerebrospinal fluid of Malawian children with malaria. J Infect Dis. 2003;188:844-849
148. Grant RS, Coggan SE, Smythe GA. The physiological action of picolinic acid in the human brain. Int J Tryptophan Res. 2009;2:271-279
149. Billker O, Lindo V, Panico M, et al. Identification of xanthurenic acid as the putative inducer of malaria development in the mosquito. Nature. 1998;392:289-292
150. Gobaille S, Kemmel V, Brumaru D, Dugave C, Aunis D, Maitre M. Xanthurenic acid distribution, transport, accumulation and release in the rat brain. J Neurochem. 2008;105:982-993
151. Badawy AA-B. Central role of tryptophan pyrrolase in haem metabolism. Biochem Soc Trans. 1979;7:575-583
152. Badawy AAB. Heme utilization by rat liver tryptophan pyrrolase as a screening test for exacerbation of hepatic porphyrias by drugs. J Pharmacol Methods. 1981;6:77-85
153. Litman DA, Correia MA. L-tryptophan: a common denominator of biochemical and neurological events of acute hepatic porphyria? Science. 1983;222:1031-1033
154. Price JM, Brown RR, Peters HA. Tryptophan metabolism in porphyria, schizophrenia, and a variety of neurologic and psychiatric diseases. Neurology. 1959;9:456-468
155. Williams JN Jr, Feigelson P, Elvehjem CA. Relation of tryptophan and niacin to pyridine nucleotides of tissues. J Biol Chem. 1950;187:597-604
156. McCreanor GM, Bender DA. The metabolism of high intakes of tryptophan, nicotinamide and nicotinic acid in the rat. Br J Nutr. 1986;56:577-586
157. Horwitt MK, Harvey CC, Rothwell WS, Cutler JL, Haffron D. Tryptophan: niacin relationships in man. J Nutr. 1956;60:1-43
158. Goldsmith GA. Niacin-tryptophan relationships in man and niacin requirement. Am J Clin Nutr. 1958;6:479-486
159. Fukuwatari T, Shibata K. Nutritional aspects of tryptophan metabolism. Int J Tryptophan Res. 2013;6:3-8
160. Jacob RA, Swendseid ME, McKee RW, Fu CS, Clemens RA. Biochemical markers for assessment of niacin status in young men: urinary and blood levels of niacin metabolites. J Nutr. 1989;119:591-598
161. Stone T, Darlington LG. Review: the kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders. Br J Pharmacol. 2013;169:1211-1227
162. Frederick R. Inhibition of the kynurenine pathway of tryptophan metabolism. In: Mittal S, ed. Targeting the Broadly Pathogenic Kynurenine Pathway. Cham: Springer; 2015:393-406
163. Sheen M, Soliman H. Clinical trials targeting the kynurenine pathway. In: Mittal S, ed. Targeting the Broadly Pathogenic Kynurenine Pathway. Cham: Springer; 2015:407-417
164. Platten M, Wick W, Van den Eynde BJ. Tryptophan catabolism in cancer: beyond IDO and tryptophan depletion. Cancer Res. 2012;72:1-6
165. Pantouris G, Mowat CG. Antitumour agents as inhibitors of tryptophan 2,3-dioxygenase. Biochem Biophys Res Commun. 2014;443:28-31
166. Pilotte L, Larrieu P, Stroobant V, et al. Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase. Proc Natl Acad Sci USA. 2012;109:2497-2502
167. Platten M, von Knebel Doeberitz N, Oesen I, Wick W, Ochs K. Cancer immunotherapy by targeting IDO1/TDO and their downstream effectors. Front Immunol. 2015;5:673
168. Hou DY, Muller AJ, Sharma MD, et al. Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses. Cancer Res. 2007;67:792-801
169. Lob S, Konigsrainer A, Schafer R, Rammensee H-G, Opelz G, Terness P. Levobut not dextro-1-methyl tryptophan abrogates the IDO activity of human dendritic cells. Blood. 2008;1111:2152-2154
170. Metz R, DuHadaway JB, Kamasani U, Laury-Kleintop L, Muller AJ, Prendergast GC. Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan. Cancer Res. 2007;67:7082-7087
171. Prendergast GC, Metz E, Muller AJ, Merlo LMF, Mandik-Nayak L. IDO2 in immunomodulation and autoimmune disease. Front Immunol. 2014;5:585
172. Nguyena NT, Kimura A, Nakahama T, Chinen E, Masuda K, Nohara K. Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism. Proc Natl Acad Sci USA. 2010;107:19961-19966
173. Stevens EA, Mezrich JD, Bradfield CA. The aryl hydrocarbon receptor: a perspective on potential roles in the immune system. Immunology. 2009;127:299-311
174. Julliard W, Fechner JH, Mezrich JD. The aryl hydrocarbon receptor meets immunology: friend or foe? A little of both. Front Immunol. 2014;5:458
175. Vogel CAF, Goth SR, Dong B, Pessah IN, Matsumura F. Aryl hydrocarbon receptor signaling mediates expression of indoleamine 2,3-dioxygenase. Biochem Biophys Res Commun. 2008;375:331-335
176. Unkila M, Pohjanvirta R, Yuomisto J. Dioxin-induced perturbations in tryptophan homeostasis in laboratory animals. Adv Exp Med Biol. 1999;467:433-442
177. Pohjanvirta R, Miettinen H, Sankari S, Hegde N, Lindén J. Unexpected gender difference in sensitivity to the acute toxicity of dioxin in mice. Toxicol Appl Pharmacol. 2012;262:167-176
178. DiNatale BC, Murray IA, Schroeder JC, et al. Kynurenic acid is a potent endogenous aryl hydrocarbon receptor ligand that synergistically induces interleukin-6 in the presence of inflammatory signaling. Toxicol Sci. 2010;115:89-97
179. Mezrich JD, Fechner JH, Zhang X, Johnson BP, Burlingham WJ, Bradfield CA. An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells. J Immunol. 2010;185:3190-3198
180. García-Lara L, Perez-Severiano F, González-Esquivel D, Elizondo G, Segovia J. Absence of aryl hydrocarbon receptors increases Endogenous kynurenic acid levels and protects mouse brain against excitotoxic insult and oxidative stress. J Neurosci Res. 2015;93:1423-1433
181. Clark CJ, Mackay GM, Smythe GA, Bustamante S, Stone TW, Phillips RS. Prolonged survival of a murine model of cerebral malaria by kynurenine pathway inhibition. Infect Immun. 2005;73:5249-5251
182. Giorgini F, Huang S-Y, Sathyasaikumar KV, et al. Targeted deletion of kynurenine 3-monooxygenase in mice: a new tool for studying kynurenine pathway metabolism in periphery and brain. J Biol Chem. 2013;288:36554-36566
183. Vengeliene V, Cannella N, Takahashi T, Spanagel R. Metabolic shift of the kynurenine pathway impairs alcohol and cocaine seeking and relapse. Psychopharmacology. 2016;233:3449-3459
184. Badawy AA-B. Kynurenic acid and alcohol and cocaine dependence: novel effects and multiple mechanisms? Psychopharmacology. 2017;234:169-171
185. Walsh HA, O'Shea KC, Botting NP. Comparative inhibition by substrate analogues 3-methoxy-and 3-hydroxydesaminokynurenine and an improved 3 step purification of recombinant human kynureninase. BMC Biochem. 2003;4:13
186. Walsh JL, Todd WP, Carpenter BK, Schwarcz R. 4-Halo-3-hydroxyanthranilic acids: potent competitive inhibitors of 3-hydroxy-anthranilic acid oxygenase in vitro. Biochem Pharmacol. 1991;42:985-990
187. Yates JR, Heyes MP, Blight AR. 4-Chloro-3-hydroxyanthranilate reduces local quinolinic acid synthesis, improves functional recovery, and preserves white matter after spinal cord injury. J Neurotrauma. 2006;23:866-881
188. Ishido K, Kamemura N, Imagawa T, Oda M, Sakurai J, Katunuma N. Quinolinate phosphoribosyl transferase, a key enzyme in de novo NAD+ synthesis, suppresses spontaneous cell death by inhibiting overproduction of active-caspase-3. Biochim Biophys Acta. 2010;1803:527-533
189. Zhang LQ, Heruth DP, Ye SQ. Nicotinamide phosphoribosyltransferase in human diseases. J Bioanal Biomed. 2011;7:13-25
190. Tan B, Young DA, Lu Z-H, et al. Pharmacological inhibition of nicotinamide phosphoribosyltransferase (NAMPT), an enzyme essential for NAD+ biosynthesis, in human cancer cells: metabolic basis and potential clinical implications. J Biol Chem. 2013;288:3500-3511
191. Zhang C, Tong J, Huang G. Nicotinamide phosphoribosyl transferase (Nampt) is a target of microRNA-26b in colorectal cancer cells. PloS ONE 2013;8:e69963
192. Verghese PB, Sasaki Y, Yang D, et al. Nicotinamide mononucleotide adenylyl transferase 1 protects against acute neurodegeneration in developing CNS by inhibiting excitotoxic-necrotic cell death. Proc Natl Acad Sci USA. 2011;108: 19054-19059
193. Bricker AL, Carey VJ, Wessels MR. Role of NADase in virulence in experimental invasive group A streptococcal infection. Infect Immun. 2005;73:6562-6566
194. Tatsuno I, Isaka M, Minami M, Hasegawa T. NADase as a target molecule of in vivo suppression of the toxicity in the invasive M-1 group A streptococcal isolates. BMC Microbiol. 2010;10:144
195. Wall KA, Klis M, Kornet J, et al. Inhibition of the intrinsic NAD+ glycohydrolase activity of CD38 by carbocyclic NAD analogues. Biochem J. 1998;335:631-636
196. Boulares AH, Yakovlev AG, Ivanova V, et al. Role of poly(ADP-ribose) polymerase (PARP) cleavage in apoptosis. Caspase 3-resistant PARP mutant increases rates of apoptosis in transfected cells. J Biol Chem. 1999;274:22932-22940
197. Bouchard VJ, Rouleau M, Poirier GG. PARP-1, a determinant of cell survival in response to DNA damage. Exp Hematol. 2003;31:446-454
198. Morales JC, Li L, Fattah FJ, Dong Y, Bey EA, Patel M, et al. Review of poly (ADP-ribose) polymerase (PARP) mechanisms of action and rationale for targeting in cancer and other diseases. Crit Rev Eukaryot Gene Expr. 2014;24:15-28
199. Curtin C, Szabo C. Therapeutic applications of PARP inhibitors: anticancer therapy and beyond. Mol Aspects Med. 2013;34:1217-1256
200. Sperber H, Mathieu J, Wang Y, et al. The metabolome regulates the epigenetic landscape during naive-to-primed human embryonic stem cell transition. Nat Cell Biol. 2015;17:1523-1535
201. Wang G-X, Zhang Y, Lv Z-W, et al. Female specific association between NNMT gene and schizophrenia in a Han Chinese population. Int J Med Sci. 2014;11:1234-1239
202. Kannt A, Pfenninger A, Teichert L, et al. Association of nicotinamide-N-methyltransferase mRNA expression in human adipose tissue and the plasma concentration of its product, 1-methylnicotinamide, with insulin resistance. Diabetologia. 2015;58:799-808
203. Zhang J, Xie X-Y, Yang S-W, Wang J, He C. Nicotinamide N-methyltransferase protein expression in renal cell cancer. J Zhejiang Univ: Sci B. 2010;11:136-143